In recent trading session, Legend Biotech Corp ADR (NASDAQ:LEGN) saw 0.91 million shares changing hands at last check today with its beta currently measuring 0.25. Company’s recent per share price level of $40.45 trading at $0.7 or 1.76% at last check today assigns it a market valuation of $7.44B. That most recent trading price of LEGN’s stock is at a discount of -50.48% from its 52-week high price of $60.87 and is indicating a premium of 32.41% from its 52-week low price of $27.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.29 million shares which gives us an average trading volume of 1.74 million if we extend that period to 3-months.
For Legend Biotech Corp ADR (LEGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Legend Biotech Corp ADR (NASDAQ:LEGN) trade information
Upright in the green today for gaining 1.76%, in the last five days LEGN remained trading in the green while hitting it’s week-highest on Thursday, 07/17/25 when the stock touched $40.45 price level, adding 1.82% to its value on the day. Legend Biotech Corp ADR’s shares saw a change of -25.08% in year-to-date performance and have moved 1.86% in past 5-day. Legend Biotech Corp ADR (NASDAQ:LEGN) showed a performance of 12.86% in past 30-days. Number of shares sold short was 14.37 million shares which calculate 6.39 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 64.5 to the stock, which implies a rise of 37.29% to its recent value today. Analysts have been projecting 54 as a low price target for the stock while placing it at a high target of 75. It follows that stock’s current price would drop -33.5% in reaching the projected high whereas dropping to the targeted low would mean a loss of -33.5% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.79% during past 5 years.
Legend Biotech Corp ADR (NASDAQ:LEGN)’s Major holders
Insiders are in possession of 1.33% of company’s total shares while institution are holding 47.77 percent of that, with stock having share float percentage of 48.42%. Investors also watch the number of corporate investors in a company very closely, which is 47.77% institutions for Legend Biotech Corp ADR that are currently holding shares of the company. FMR LLC is the top institutional holder at LEGN for having 17.62 million shares of worth $780.46 million. And as of 2024-06-30, it was holding 9.6503 of the company’s outstanding shares.
The second largest institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, which was holding about 11.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.292 of outstanding shares, having a total worth of $508.86 million.
On the other hand, Fidelity Select Portfolios-Health Care Portfolio and AIM Investment Fd.s -Invesco Developing Markets Fd. are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 3.45 shares of worth $139.33 million or 1.88% of the total outstanding shares. The later fund manager was in possession of 2.69 shares on Apr 30, 2025 , making its stake of worth around $108.45 million in the company or a holder of 1.46% of company’s stock.
